Statins decrease the occurrence of venous thromboembolism in patients with cancer

The American Journal of Medicine
Danai KhemasuwanGlenn Eiger

Abstract

Recent data suggest a reduction in the occurrence of venous thromboembolism in select groups of patients who use statins. The objective of this study is to evaluate the impact of statin use on the occurrence of venous thromboembolism in patients with solid organ tumor. We conducted a retrospective, case-control study reviewing 740 consecutive patients with a diagnosis of solid organ tumor who were admitted to the Albert Einstein Medical Center, Philadelphia, Penn, between October 2004 and September 2007. Patients treated with anticoagulation therapy before their first admission were excluded. The occurrence of venous thromboembolism, risk factors for venous thromboembolism, and statin use were recorded. Patients who never used statins or had used them for less than 2 months were relegated to the control group. The mean age of the study population was 65 years, and 52% of the patients were women and 76% were African American. The occurrence of venous thromboembolism was 18% (N=132), and 26% (N=194) were receiving statins. Among patients receiving statins, 8% (N=16) developed a venous thromboembolism compared with 21% (N=116) in the control group (odds ratio 0.33; 95% confidence interval, 0.19-0.57). A logistic regression analysi...Continue Reading

References

Oct 23, 1997·Thrombosis Research·T KawasakiM Monden
Jan 19, 2000·Circulation·D J MaronM F Linton
Aug 3, 2001·Archives of Internal Medicine·J G RayA Laupacis
Oct 31, 2002·Neoplasia : an International Journal for Oncology Research·Graham J CaineSean T Kehoe
Nov 20, 2002·Expert Opinion on Investigational Drugs·Joel G Ray
Jan 21, 2006·Journal of Cardiovascular Pharmacology·Aura G GiurgeaMehrdad Baghestanian
Feb 27, 2007·Journal of Thrombosis and Haemostasis : JTH·A A KhoranaG H Lyman
Mar 21, 2007·Circulation·Sabine EichingerJohn H Griffin
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Mar 31, 2009·The New England Journal of Medicine·Robert J GlynnPaul M Ridker

❮ Previous
Next ❯

Citations

May 18, 2011·Herz·M Noutsias, B Maisch
Sep 14, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D ViasusJ Carratalà
Jan 27, 2012·Journal of Thrombosis and Thrombolysis·April L RodriguezJose A Diaz
May 11, 2011·International Journal of General Medicine·Christos G Mihos, Orlando Santana
Oct 25, 2013·Journal of Thrombosis and Thrombolysis·Ayelet ShaiGad Rennert
Jan 29, 2016·Thrombosis and Haemostasis·Vicky TagalakisLaurent Azoulay
Jan 29, 2014·Surgery·James C IannuzziFergal J Fleming
Jul 26, 2011·The American Journal of Medicine·Danai KhemasuwanJorge I Mora
Feb 1, 2011·Pharmacology & Therapeutics·Christos VaklavasApostolia Maria Tsimberidou
Aug 24, 2010·Progress in Cardiovascular Diseases·Ronald J Krone
Aug 24, 2010·Progress in Cardiovascular Diseases·Douglas L Mann, Ronald J Krone
Nov 29, 2013·Thrombosis and Haemostasis·A UndasK G Mann
May 20, 2015·Journal of Thrombosis and Haemostasis : JTH·Y HisadaN Mackman
Jan 28, 2010·The American Journal of Medicine·James E Dalen
Oct 2, 2015·Indian Journal of Endocrinology and Metabolism·Narasaraju KavalipatiHardik Vasnawala
May 10, 2011·Revista portuguesa de pneumologia·L Jara-PalomaresE Barrot-Cortes
Mar 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Linnea A PolgreenPhilip M Polgreen
Mar 19, 2014·Gynecologic Oncology·Ayelet ShaiOfer Lavie
Mar 27, 2018·Journal of Thrombosis and Haemostasis : JTH·S AdesM Cushman
Nov 23, 2011·Pharmacological Reviews·Patrizia GazzerroMaurizio Bifulco
Jun 9, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Yaping FengMingyi Zhang
Mar 19, 2011·Current Opinion in Clinical Nutrition and Metabolic Care·Carla M M PradoVickie E Baracos
Oct 23, 2012·Hospital Practice·Amikar SehdevRobert C Pendleton
May 10, 2018·Frontiers in Neurology·Ye Sel KimWoo-Keun Seo
Jan 18, 2019·Cancers·Silvia RiondinoFiorella Guadagni
Apr 9, 2018·Current Treatment Options in Cardiovascular Medicine·Mirela TuzovicEric H Yang
May 15, 2021·Seminars in Thrombosis and Hemostasis·José Costa, António Araújo
May 9, 2021·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Peter E FrascoAmit K Mathur
Oct 20, 2017·European Journal of Internal Medicine·Claire De MoreuilAurélien Delluc
Aug 13, 2010·Current Opinion in Supportive and Palliative Care

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Heart Journal
Alessandro SquizzatoWalter Ageno
The American Journal of Medicine
Igor KarpLouise Pilote
JAMA : the Journal of the American Medical Association
Bakhtawar K MahmoodiPrevention of Renal and Vascular End-stage Disease (PREVEND) Study Group
© 2021 Meta ULC. All rights reserved